i-SEP
i-SEP is a French medtech company founded in 2015 in Nantes, specializing in intraoperative autotransfusion and Patient Blood Management. They develop and market innovative, patented blood component separation technology, aiming to improve patient care, simplify physician workflows, and reduce healthcare costs. Their solutions focus on autotransfusion, allowing recovery of both red blood cells and platelets during hemorrhagic surgeries, thus reducing reliance on donor blood and associated risks.
Industries
Nr. of Employees
small (1-50)
i-SEP
21 Rue de la Nouë Bras de Fer, 44200 Nantes, France
Patents
Products
Intraoperative autotransfusion system (recovers red blood cells and platelets)
A medical device used during hemorrhagic or high-risk surgery to collect, process and retransfuse a patient’s blood, designed to recover both red blood cells and platelets and to integrate into operating-room workflows.
Intraoperative autotransfusion system (recovers red blood cells and platelets)
A medical device used during hemorrhagic or high-risk surgery to collect, process and retransfuse a patient’s blood, designed to recover both red blood cells and platelets and to integrate into operating-room workflows.
Services
Design and execution of clinical evaluations, post-market clinical follow-up and registry data collection to monitor safety and performance under MDR.
Prototype to production workflows including clean-room assembly, validation batches and industrialization of single-use consumables for the autotransfusion system.
On-site deployment support, user training and workflow integration for operating-room teams to adopt autotransfusion into patient blood management programs.
Implementation and maintenance of a certified quality management system and support for regulatory submissions, CE marking under MDR and interactions with competent authorities.
Design and execution of clinical evaluations, post-market clinical follow-up and registry data collection to monitor safety and performance under MDR.
Prototype to production workflows including clean-room assembly, validation batches and industrialization of single-use consumables for the autotransfusion system.
On-site deployment support, user training and workflow integration for operating-room teams to adopt autotransfusion into patient blood management programs.
Implementation and maintenance of a certified quality management system and support for regulatory submissions, CE marking under MDR and interactions with competent authorities.
Expertise Areas
- Intraoperative autotransfusion and cell salvage
- Patient Blood Management (PBM)
- Clinical trial execution and post-market clinical follow-up
- Medical device R&D and prototyping
Key Technologies
- Autotransfusion and intraoperative cell salvage
- Blood component separation and concentration
- Platelet recovery methods
- Filtration cycles aligned with surgical workflow
News & Updates
European Society of Anaesthesiology and Intensive Care Congress
i-SEP presented their technology and discussed the benefits of autotransfusion, including reducing blood product use and improving patient recovery.
NATA Congress 2024
i-SEP showcased their same™ technology, emphasizing its role in redefining transfusion strategies and its benefits in reducing donor blood dependency.
NATA Congress 2023
i-SEP participated in discussions on blood management and autotransfusion, highlighting their innovative solutions.
CAPSO Congress 2023
i-SEP presented their technology and clinical results, demonstrating the recovery of both red blood cells and platelets.
EACTA 2023
i-SEP shared clinical experiences and the impact of their technology in cardiac surgery.
A study on the use of same™ device showing effective recovery of blood components during on-pump cardiac surgery.
European Society of Anaesthesiology and Intensive Care Congress
i-SEP presented their technology and discussed the benefits of autotransfusion, including reducing blood product use and improving patient recovery.
NATA Congress 2024
i-SEP showcased their same™ technology, emphasizing its role in redefining transfusion strategies and its benefits in reducing donor blood dependency.
NATA Congress 2023
i-SEP participated in discussions on blood management and autotransfusion, highlighting their innovative solutions.
CAPSO Congress 2023
i-SEP presented their technology and clinical results, demonstrating the recovery of both red blood cells and platelets.
EACTA 2023
i-SEP shared clinical experiences and the impact of their technology in cardiac surgery.
A study on the use of same™ device showing effective recovery of blood components during on-pump cardiac surgery.